MHRA recalls batches of betahistine dihydrochloride tablets

Latest

MHRA recalls batches of betahistine dihydrochloride tablets

In Latest

The Medicines and Healthcare products Regulatory Agency has issued a recall for batches of betahistine dihydrochloride 8mg and 16mg tablets.

The regulator advised healthcare professionals to stop supplying certain batches immediately, quarantine all stock and return it to their supplier after what it described as “a cross-contamination issue:.

“Kent Pharmaceuticals Ltd has informed us that several batches of finished product were contaminated with theophylline due to a cross-contamination issue identified with an excipient that was used in the manufacture of the finished product,” the MHRA said.

The affected 8mg batches of are EC10619, EC10719, EC10819 while the 16mg batches are GY11119, GY11219 and GY11319.

“The risk of adverse reactions is low with respect to the level of contamination. However, if patients experience any side effects related to hypersensitivity or those not normally experienced with betahistine, please ensure appropriate clinical advice is sought from your healthcare team. Any suspected side effects should also be reported via the Yellow Card scheme,” the MHRA said.

Record my learning outcomes

Latest

Inspiring stories related to health, fitness and the pursuit of wellbeing

Share:

More like this

bookmark_icon_off
Latest

BAME risk assessments ‘must be carried out within weeks’

Employers must carry out Covid-19 risk assessments for all staff in at-risk groups within the next few weeks, NHS England & Improvement has said.

1 Min Article

bookmark_icon_off
Latest

Help Us Help You Pharmacy Advice campaign launch

NHS England and NHS Improvement to launch an updated Help Us Help You Pharmacy Advice campaign on 20 January.

1 Min Article

bookmark_icon_off
Latest

MPs launch inquiry into the impact of pandemic on pharmacy

The All-Party Pharmacy Group is warning that Covid-19 is posing an existential threat to the sector.

1 Min Article

bookmark_icon_off
Latest

Urgent recall on 4,400 Co-codamol tablets

MHRA is urgently recalling packs of Co-codamol effervescent tablets amid concerns they may contain too much or too little of the active ingredients.

 

1 Min Article

bookmark_icon_off
Latest

Reciprocal EU healthcare arrangements confirmed

EHIC/E111s remain valid but will be replaced by new Global Health Insurance Card on expiry.

1 Min Article

bookmark_icon_off
Latest

Another 65 pharmacies begin Covid vaccinations

Sixty-five community pharmacy-led vaccination sites have this week become part of the coronavirus vaccination programme in England.

1 Min Article

Recommended Learning

Sponsored modules

Supporting women in their contraceptive choices

Upgrade your contraceptive consultations by exploring the interactive pack to learn about a daily oral contraceptive pill

8 Min Module

bookmark_icon_off
Sponsored modules

Indigestion update

Update your knowledge on indigestion with this short video and discover a new dual-action product you can recommend.

3 Min Module

bookmark_icon_off
Sponsored modules

OTC Omeprazole tablets 20mg: an opportunity for pharmacy

This module highlights a new opportunity to treat heartburn and reflux in the pharmacy with Omeprazole 20mg, which is newly available for customers to purchase OTC.

10 Min Module

Sponsored modules

7 steps to tackling children's allergy

Work through this new-style module to increase your confidence in reassuring parents of children with allergies, and know what advice and products to recommend

8 Min Module

Videos

Advising on constipation treatments

Discover the key benefits of different types of laxatives, and the right questions to ask customers to ensure you know which to recommend

2 Min Module

bookmark_icon_off
Sponsored modules

Sore throats and antibiotic resistance

This module will help you to understand and educate customers about the risks of antibiotic resistance, and recommend products to help them effectively manage their sore throat symptoms.

 

10 Min Module